Literature DB >> 20924223

Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers.

F A Costa-Barbosa1, V M Carvalho, O H Nakamura, T A S S Bachega, J G H Vieira, C E Kater.   

Abstract

INTRODUCTION: Although much is known about the increased levels of the 21-hydroxylase substrates 17-hydroxyprogesterone (17OHP) and 21-deoxycortisol (21DF) - the biochemical markers of all forms of 21-hydroxylase deficiency (21OHD), only limited information is available on the zona fasciculata (ZF) products distal to the enzymatic block: 11-deoxycortisol (S), 11-deoxycorticosterone (DOC), and corticosterone (B).
OBJECTIVE: To investigate whether basal and post-ACTH levels of S, DOC, and B and the 21-hydroxylase precursor-to-product ratios determined by tandem mass spectrometry preceded by high-performance liquid chromatography separation (liquid chromatography-tandem mass spectrometry) could disclose distinct profiles in genotypically confirmed classic (no.=14) and non-classic (NC) (no.=18) patients, heterozygote carriers (no.=61) and wildtypes (WT) (no.=27) for 21OHD.
RESULTS: Salt wasting (SW) and simple virilizing (SV) had higher basal levels of DOC with no further increase in response to ACTH. Stimulated DOC was similar in 21OHD patients and carriers but was reduced as compared to WT. ACTH-stimulated B increased gradually from SW and SV through WT. The post-ACTH 21DF/B ratio was able to detect 92% of the carriers among WT. All NC patients could be detected by post-ACTH 17OHP/DOC and 21DF/B, with no overlap with 21OHD carriers.
CONCLUSION: Although 21-hydroxylase is a key enzymatic step in both 17-hydroxy and 17-deoxy pathways of ZF, the reaction is mostly affected in the latter pathway, leading to a significant impairment of B production, which may further characterize the 21OHD subtypes. Also, the precursor-to-product ratios, particularly 21DF/B, can demonstrate the distinctive outline of 21OHD subtypes, including carriers and normal subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924223     DOI: 10.3275/7273

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Congenital adrenal hyperplasia.

Authors:  Phyllis W Speiser; Perrin C White
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

2.  Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

Authors:  H Yamazaki; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-10-01       Impact factor: 4.013

Review 3.  Extensive clinical experience: nonclassical 21-hydroxylase deficiency.

Authors:  Maria I New
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

4.  Regulation of 21-hydroxylase activity by steroids in cultured bovine adrenocortical cells: possible significance for adrenocortical androgen synthesis.

Authors:  P J Hornsby
Journal:  Endocrinology       Date:  1982-10       Impact factor: 4.736

5.  Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  T A Bachega; A E Billerbeck; J A Marcondes; G Madureira; I J Arnhold; B B Mendonca
Journal:  Clin Endocrinol (Oxf)       Date:  2000-05       Impact factor: 3.478

6.  Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.

Authors:  Flávia A Costa-Barbosa; Vânia F Tonetto-Fernandes; Valdemir M Carvalho; Odete H Nakamura; Vivian Moura; Tânia A S S Bachega; José G H Vieira; Claudio E Kater
Journal:  Clin Endocrinol (Oxf)       Date:  2010-12       Impact factor: 3.478

7.  Extraadrenal steroid 21-hydroxylation is not mediated by P450c21.

Authors:  S H Mellon; W L Miller
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

8.  Steroid hydroxylations by human adrenal cortex microsomes 1, 2.

Authors:  E B Nelson; G T Bryan
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

Review 9.  Mineralocorticoids in congenital adrenal hyperplasia.

Authors:  E G Biglieri; C E Kater
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

10.  Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.

Authors:  D P Pardini; C E Kater; J G Vieira; E G Biglieri
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

View more
  6 in total

1.  Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.

Authors:  Adina F Turcu; Juilee Rege; Robert Chomic; Jiayan Liu; Hiromi K Nishimoto; Tobias Else; Andreas G Moraitis; Ganesh S Palapattu; William E Rainey; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2015-04-07       Impact factor: 5.958

Review 2.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

3.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.

Authors:  Sandra R Dahl; Ingrid Nermoen; Ingeborg Brønstad; Eystein S Husebye; Kristian Løvås; Per M Thorsby
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

5.  Abiraterone acetate treatment lowers 11-oxygenated androgens.

Authors:  Connor Wright; Patrick O'Day; Mohammed Alyamani; Nima Sharifi; Richard J Auchus
Journal:  Eur J Endocrinol       Date:  2020-04       Impact factor: 6.664

6.  Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation.

Authors:  Adina F Turcu; Diala El-Maouche; Lili Zhao; Aya T Nanba; Alison Gaynor; Padma Veeraraghavan; Richard J Auchus; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.